Enhanced depth imaging optical coherence tomography in long-standing Vogt–Koyanagi–Harada disease

Gaspar, F. T.; Sakata, Viviane Mayumi; Hirata, Carlos Eduardo; Oliveira, Cristiana Dumaresq de; Takahashi, Walter Yukihiko; Olivalves, Edilberto; Costa, R. A.; Yamamoto, Joyce Hisae

doi:10.1136/bjophthalmol-2012-302089

Cited by 98 publications

(62 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our result suggests that SFCT may also be used to monitor disease activity in chronic VKH. However, SFCT is also negatively correlated with age and duration of disease, which is consistent with other studies 26 27. In this retrospective study, there was wide variation in the baseline duration of disease and SFCT.…”

Section: Discussionsupporting

confidence: 92%

The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease

Jap

2016

Br J Ophthalmol

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 92%

The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease

Jap

2016

Br J Ophthalmol

View full text Add to dashboard Cite

show abstract

“…The CT in myopia also has a positive correlation with final visual acuity. 21,22 In polypoidal choroidal vasculopathy, 23 Vogt-Koyanagi-Harada disease, 24 and Behçet's disease, 25 the choroid is thickened during the active phase and thereafter shows progressive thinning. The CT, therefore, has the potential to be used as a parameter to monitor the activity of these diseases.…”

Section: Discussionmentioning

confidence: 99%

Subfoveal choroidal thickness as a predictor of central serous chorioretinopathy

Ambiya

Yogi

et al. 2016

Eye

View full text Add to dashboard Cite

Purpose The purpose of the study was to evaluate the role of subfoveal choroidal thickness (CT) measurements as a predictor for the course of central serous chorioretinopathy (CSC). Patients and methods Thirty-eight eyes of 33 patients with CSC were analyzed retrospectively. Key inclusion criteria were naive (acute or recurrent) CSC; a minimum of 12 months of follow up; and the availability of good quality enhanced depth imaging SD-OCT images at each visit. Eyes with changes suggestive of chronic CSC and history of any treatment were excluded. Collected data included demographic profile, visual acuity, subfoveal CT, central macular thickness (CMT), and treatment details. Univariate and multivariate analyses for association of baseline features with need for treatment were performed. On the basis of results of this analysis, the 38 eyes were divided into two groups: Group A (subfoveal CT ≤ 356 μm) and Group B (subfoveal CT4356 μm). Results On univariate analysis, the need for treatment had significantly positive correlation with duration of symptoms (P = 0.02), negative correlation with the baseline CT (Po0.01), and no significant correlation with CMT (P = 0.13). On multivariate regression analysis, only baseline CT had a statistically significant association with the need for treatment (odds ratio (OR), 0.989; CI, 0.979-0.999; P = 0.048). Group A eyes were more likely to require treatment (Group A: 54.55%, 12 of 22 eyes; Group B: 18.75%, 3 of 16 eyes; OR: 5.2, 95% CI, 1.15-23.54; P = 0.04). There was a significant decrease in subfoveal CT in Group B (−105.62 ± 108.91 μm; P = 0.002). Conclusion CSC with a subfoveal CT ≤ 356 μm is of chronic nature and is more likely to require treatment rather than observation.

show abstract

“…Many researchers have recently reported choroidal findings such as changes in the choroidal thickness or loss of the choriocapillaris in patients with VKH disease by utilizing enhanced depth imaging, spectral-domain opti-DOI: 10.1159/000481863 cal coherence tomography (SD-OCT), or swept-source optical coherence tomography [7][8][9][10][11]. However, a few retrospective studies have reported retinal findings such as changes in the inner retinal thickness in patients with VKH disease by using enhanced SD-OCT and have identified a correlation between the retinal pigment epithelium undulation index and changes in the retinal thickness in eyes with VKH disease [12,13].…”

Section: Introductionmentioning

confidence: 99%

Changes in Central Macular Thickness and Retinal Nerve Fiber Layer Thickness in Eyes with Vogt-Koyanagi-Harada Disease: A 2-Year Follow-Up Study

et al. 2018

View full text Add to dashboard Cite

Purpose: To investigate the central macular thickness (CMT) and retinal nerve fiber layer (RNFL) thickness in eyes with Vogt-Koyanagi-Harada (VKH) disease associated with optic disc swelling and serous retinal detachment through a 24-month follow-up period. Methods: We prospectively investigated 28 eyes of 14 treatment-naïve patients with acute VKH disease associated with optic disc swelling and serous retinal detachment and 30 eyes of 15 normal individuals to compare changes in the CMT and average RNFL thickness. Results: The CMT was significantly lower in the eyes of the VKH group at 12 and 24 months. The RNFL thickness was significantly higher in the eyes of the VKH group at the initial visit and at the 6- and 12-month follow-up visits, but no significant difference was found between the VKH group and control group at the 24-month follow-up visit. Conclusion: Significant changes in the CMT and RNFL thickness in the eyes with VKH disease were observed during the 24-month follow-up period. When diagnosing or monitoring diseases including glaucoma and neuro-ophthalmic diseases that affect the retinal thickness in patients with VKH disease, we recommend considering longitudinal changes in the retinal thickness.

show abstract

Enhanced depth imaging optical coherence tomography in long-standing Vogt–Koyanagi–Harada disease

Cited by 98 publications

References 25 publications

The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease

The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease

Subfoveal choroidal thickness as a predictor of central serous chorioretinopathy

Changes in Central Macular Thickness and Retinal Nerve Fiber Layer Thickness in Eyes with Vogt-Koyanagi-Harada Disease: A 2-Year Follow-Up Study

Contact Info

Product

Resources

About